AG真人官方

Intellia Therapeutics, Inc. (NTLA) 鈥� Form 4 insider filing

EVP & CFO Edward J. Dulac III executed an automatic, non-volitional sale of 7,462 common shares on 23 Jul 2025 at $14.02 per share. The disposition was a mandatory 鈥渟ell-to-cover鈥� to satisfy federal and state tax-withholding obligations triggered by the vesting of RSUs on 22 Jul 2025.

Post-transaction, Dulac directly owns 106,062 NTLA shares; no indirect holdings or derivative security changes were reported. No options were exercised or granted, and the filing does not disclose any additional share sales or purchases.

The event does not materially alter management鈥檚 economic exposure to the company and should be viewed as administrative rather than discretionary trading activity.

Regulus Therapeutics Inc. filed Post-Effective Amendment No. 1 to 20 previously effective Form S-8 registration statements on 25 June 2025. The amendment deregisters all shares of common stock that had been registered but remain unsold or unissued under the company鈥檚 2009, 2012, 2019 and 2021 equity incentive plans, multiple inducement plans and its 2012 and 2022 employee stock purchase plans. Collectively, the affected filings span registrations made between 2012 and 2025 and reference two reverse stock splits (1-for-12 in 2018 and 1-for-10 in 2022).

The action follows completion of the merger stipulated in the 29 April 2025 Agreement and Plan of Merger among Regulus, Novartis AG and Redwood Merger Sub Inc. On 25 June 2025, Redwood Merger Sub merged with and into Regulus, leaving Regulus as a wholly-owned subsidiary of Novartis. Because the company is now private, it has terminated all offerings of its securities, rendering the original S-8 registrations unnecessary.

Operationally, Regulus is identified as a non-accelerated filer and a smaller reporting company. No financial statements, valuation data or pro-forma disclosures are included; the filing is purely administrative. For investors, the document confirms the cessation of future share issuances under employee and incentive plans and provides final regulatory closure on Regulus鈥� transition from a public issuer to part of Novartis.

Forward Industries, Inc. (NASDAQ: FORD) has released its 2025 Definitive Proxy Statement (DEF 14A) for the virtual Annual Meeting scheduled on August 8, 2025. The document outlines eight proposals that shareholders of record on June 18, 2025 (1,125,998 common shares outstanding) will vote on.

Key Proposals:

• Proposal 1 鈥� Election of three directors.
• Proposal 2 鈥� Ratification of the independent registered public accounting firm for FY 2025.
• Proposal 3 鈥� Reincorporation from New York to Nevada via a merger with a wholly-owned Nevada subsidiary (see Annex A).
• Proposal 4 鈥� Nasdaq 20 % Issuance Proposal (ELOC): Approval to issue common shares above the 20 % threshold pursuant to a May 16 2025 equity line of credit agreement with C/M Capital Master Fund, LP.
• Proposal 5 鈥� Nasdaq 20 % Issuance Proposal (Series B): Approval to issue shares upon conversion of Series B Preferred Stock and related warrants sold on May 23 2025 to two investors, again above the 20 % cap.
• Proposal 6 鈥� 2021 Equity Incentive Plan Amendment: Increase share reserve by 300,000 to a total of 429,100 shares.
• Proposal 7 鈥� Possible adjournment to solicit additional proxies if needed.
• Proposal 8 鈥� Other business that may properly come before the meeting.

The meeting will be virtual-only via www.virtualshareholdermeeting.com/FWD2025; shareholders can vote in advance online, by phone, by mail, or during the webcast using their 16-digit control number.

Capital Structure Implications: Proposals 4, 5, and 6 collectively authorize a significant increase in share issuances, potentially diluting existing holders. The equity line of credit provides flexible access to capital, while the Series B conversion rights and the enlarged option pool expand financing and compensation tools.

Governance & Administrative Items: Reincorporation could align the company with Nevada鈥檚 more company-friendly statutes. No filing fee is required for this proxy, and the board recommends shareholders vote via Internet, telephone, mail, or during the meeting to ensure quorum.

Forward Industries, Inc. (NASDAQ: FORD) filed a Form 8-K dated June 16, 2025 announcing a governance change to its Third Amended and Restated Bylaws. The Board approved Amendment No. 1, revising Article II, Section 205 to reduce the shareholder meeting quorum requirement from a majority of outstanding shares to 33.3% of shares entitled to vote, present in person or by proxy. No other material items, financial data or transactions were disclosed. The amendment is provided as Exhibit 3.1; the filing also includes the Inline XBRL cover page (Exhibit 104). Signed by CFO Kathleen Weisberg on June 18, 2025.